London, ENG– Fabric with color-changing aspects have been tinkered with in the fashion industry for some time now. But researchers from the University of Bath in London are looking to take this idea and apply it to healthcare and ultimately solve major issues in the detection of deadly infections.

The researchers have just released a prototype of a color-changing bandage that glows bright green to signify signs of a potential wound infection. The product (still in prototype stage) is poised to decrease the amount of overprescribing of antibiotics that occurs every year and proactively spot early signs of infection well before a patient gets sick.

These bandages are lined with an outer layer of a dye-containing capsule that pop when they come in contact with certain toxins within the bacteria. Once enough toxins are detected, microbes prompt the release of the dye that turns bright green when it mixes with the bandage lining.

About the Author:

As Managing Director of Innovation for Syneos Health Communications, Leigh is responsible for shaping the company’s perspective on the next era of healthcare marketing. Through thought leadership, strategic innovation workshops and new products and capabilities, Leigh focuses on identifying marketing approaches that will fuel that new era and generate significant growth for clients. Leigh has worked with Fortune 1000 companies to craft their digital, mobile, social and CRM strategies for over 17 years. She’s worked for category-leading agencies in retail, public affairs, B2B technology, and higher education. Prior to moving to Syneos Health Communications, she had several leadership roles at one of our agencies, GSW. There, she founded an innovation practice fueled by the zeitgeist and spearheaded digital and innovation thinking across the business. Leigh has taken a special interest in complex healthcare products that can change lives in meaningful ways. She was recently a strategic lead on the 3rd largest launch in pharmaceutical history: Tecfidera. Before that she had keys roles with Eli Lilly Oncology, Abbott Nutrition, Amgen Cardiovascular, and Eli Lilly Diabetes. A critical part of Leigh’s work is trends and new ideas. Every year, she convenes a group of trend watchers from across our global network to identify the shifts most critical to healthcare marketers. Leigh is a sought-after writer and speaker. Recognized as one of the most inspiring people in the pharmaceutical industry by PharmaVoice, Leigh also was recognized as a Rising Star by the Healthcare Businesswomen's Association (HBA) for her overt passion, industry thought leadership and significant contributions in new business, strategy and mentoring.